Dermatology News and Research

Latest Dermatology News and Research

Scientists, advocacy experts form new international Foundation for Vaccine Research

Fourteen leading scientists and advocacy experts in vaccines and infectious diseases have announced the formation of a new international Foundation to advance and accelerate vaccine research and development against infectious diseases.

9 Jun 2011

Doctors' move to electronic records requires serious commitment

The federal stimulus and health care laws are pushing medical providers to go electronic as a way to improve patient safety and track health care quality. ... But moving away from paper files to an electronic health record system requires serious commitment on several levels. First, they're expensive. ... Second, the learning curve can be painful.

8 Jun 2011

FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations

Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug Application (NDA) for the use of ivermectin topical cream as a treatment for head lice infestations in children and adults.

7 Jun 2011

NYC dermatologist announces website launch of BeautyRx Skincare

To introduce BeautyRx Skincare, Neal Schultz, M.D., board-certified New York City dermatologist, proudly announces the website launch of BeautyRx.com. The site will unveil his new line of skincare products forged from insider advances in cosmeceutical technology, and developed over 10 years with ongoing patient feedback from his 10,000 patient visits per year.

7 Jun 2011

LWW sponsors 26th Annual Clinical Symposium on Advances in Skin & Wound Care

The 26th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing will be held September 9-12, 2011, at the Gaylord National Hotel & Convention Center, National Harbor, MD.

7 Jun 2011

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Halozyme Therapeutics, Inc. and Intrexon Corporation, today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous injectable formulation of Intrexon Corporation's recombinant human alpha 1-antitrypsin (rHuA1AT).

7 Jun 2011

Majority of Canadian parents concerned about sun protection for children, CDA survey

Almost all Canadian parents (92%) are concerned about sun protection for their children, a new survey for the Canadian Dermatology Association (CDA) shows.

6 Jun 2011

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

Genentech, a member of the Roche Group and Astellas Pharma US, Inc., today announced results of EURTAC, the first Phase III study with Tarceva in Western patients with a genetically distinct type of advanced non-small cell lung cancer (NSCLC).

4 Jun 2011

PCF funds 14 new Creativity Awards for advanced prostate cancer research

The Prostate Cancer Foundation today announced that it has funded 14 new Creativity Awards for advanced prostate cancer research. These two-year awards are designed to support innovative research ideas that have the potential to achieve breakthroughs for improved prostate cancer diagnosis and treatment.

2 Jun 2011

Invida announces launch of novel atopic dermatitis symptomatic treatment

Invida Group Private Limited reaffirmed its commitment to patients in Asia Pacific by announcing the launch of a novel atopic dermatitis symptomatic treatment, Atopiclair, which will be available to patients across Asia in second half of 2011.

26 May 2011

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

New findings to be presented from pooled analyses of the STELARA psoriasis clinical development program showed that the safety profile of STELARA and rates of adverse events remained consistent and stable over time in adults with moderate to severe plaque psoriasis receiving up to four years of treatment.

25 May 2011

Patient accrual complete in Provectus PH-10 Phase 2C clinical trial for treatment of psoriasis

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has completed patient accrual in its Phase 2C clinical trial of PH-10 for the treatment of psoriasis. PH-10, an aqueous hydrogel formulation of Rose Bengal disodium for topical administration to the skin, is being studied for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis.

24 May 2011

Scientific evidence supports benefits of sunscreen usage to prevent skin cancer

The American Academy of Dermatology today reiterated the safety and effectiveness of sunscreens to protect against the damaging effects from exposure to ultraviolet (UV) radiation. As one component of a daily sun-protection strategy, sunscreen is an important tool in the fight against skin cancer, including melanoma, the deadliest form of skin cancer.

24 May 2011

Valeant to acquire Sanitas for EUR314 million

Valeant Pharmaceuticals International, Inc. today announced that it has agreed to acquire AB Sanitas for approximately EUR314 million in cash.

24 May 2011

Phytoceuticals to present promising clinical data on 1 PRIMARY WOUND DRESSING at EWMA 2011

Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.

23 May 2011

Jennerex presents positive preliminary data from JX-594 Phase 2 trial for advanced liver cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the design, development and commercialization of first-in-class targeted oncolytic products for cancer, today presented preliminary data from a randomized dose-ranging Phase 2 trial of JX-594 in patients with advanced liver cancer showing a benefit in overall survival for the high dose group.

20 May 2011

XTRAC Excimer Laser treatment offers new hope for patients with psoriasis

With XTRAC® Excimer Laser treatments, psoriasis patients can say goodbye to the red, dry patches of scaly, thickened skin they have been covering up all winter. Developed by PhotoMedex, Inc., an innovator of medical devices, the XTRAC laser offers new hope to the 7.5 million Americans suffering from this embarrassing and socially isolating disease.

19 May 2011

Takeda reaches agreement to acquire Nycomed

Takeda Pharmaceutical Company Limited and Nycomed A/S jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for 9.6 billion Euro on a cash-free, debt-free basis.

19 May 2011

Study suggests link between obesity, psoriasis and heart disease risk in children

Children who are overweight or obese have a significantly higher prevalence of psoriasis, and teens with psoriasis, regardless of their body weight, have higher cholesterol levels, according to a Kaiser Permanente study published online in the Journal of Pediatrics.

19 May 2011

'Gatekeeper' protein plays a key role in skin-cancer prevention

New research from North Carolina State University shows that a "gatekeeper" protein plays an important role in skin-cancer prevention in humans and lab mice.

19 May 2011

Dermatology News and Research

Latest Dermatology News and Research

Scientists, advocacy experts form new international Foundation for Vaccine Research

Doctors' move to electronic records requires serious commitment

FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations

NYC dermatologist announces website launch of BeautyRx Skincare

LWW sponsors 26th Annual Clinical Symposium on Advances in Skin & Wound Care

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Majority of Canadian parents concerned about sun protection for children, CDA survey

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

PCF funds 14 new Creativity Awards for advanced prostate cancer research

Invida announces launch of novel atopic dermatitis symptomatic treatment

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

Patient accrual complete in Provectus PH-10 Phase 2C clinical trial for treatment of psoriasis

Scientific evidence supports benefits of sunscreen usage to prevent skin cancer

Valeant to acquire Sanitas for EUR314 million

Phytoceuticals to present promising clinical data on 1 PRIMARY WOUND DRESSING at EWMA 2011

Jennerex presents positive preliminary data from JX-594 Phase 2 trial for advanced liver cancer

XTRAC Excimer Laser treatment offers new hope for patients with psoriasis

Takeda reaches agreement to acquire Nycomed

Study suggests link between obesity, psoriasis and heart disease risk in children

'Gatekeeper' protein plays a key role in skin-cancer prevention

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dermatology News and Research

Latest Dermatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in